Viewing Study NCT06005532


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2025-12-25 @ 7:22 PM
Study NCT ID: NCT06005532
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-07-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
Sponsor: Mabscale, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module